Dow Up 0.36% Nasdaq Up 0.12%

InVivo Therapeutics Holdings Corp. (NVIV)

-Other OTC
0.69 Up 0.02(2.24%) 3:59PM EDT
Prev Close:0.67
Open:0.67
Bid:N/A
Ask:N/A
1y Target Est:3.00
Beta:1.13
Next Earnings Date:N/A
Day's Range:0.66 - 0.71
52wk Range:0.63 - 4.25
Volume:200,947
Avg Vol (3m):213,027
Market Cap:64.00M
P/E (ttm):N/A
EPS (ttm):-0.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVIV

Comparison

Symbol% ChgMkt Cap
NVIVUp 2.24%64.00M
ACORUp 0.99%1.30B
ALSE 0.00%1.07M
STEMDown 1.28%105.70M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.20
Quarterly EPS Est (Sep-14) :-0.05
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biomaterial technologies for the treatment of spinal cord injuries and hydrogels for therapeutics delivery. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback